Landtblom, Anna Ravn
Andersson, Therese M-L
Dickman, Paul W
Smedby, Karin E
Eloranta, Sandra
Batyrbekova, Nurgul
Samuelsson, Jan
Björkholm, Magnus
Hultcrantz, Malin http://orcid.org/0000-0002-9045-6495
Funding for this research was provided by:
Blodcancerfonden, the Cancer Research Foundations of Radiumhemmet
Åke Olsson Foundation for Hematologic Research, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet
Memorial Sloan-Kettering Cancer Center (P30 CA008748)
Article History
Received: 28 March 2020
Revised: 25 May 2020
Accepted: 3 June 2020
First Online: 16 June 2020
Conflict of interest
: Andersson, Smedby, Eloranta, and Björkholm are involved in an ongoing public-private real world evidence collaboration between Karolinska Institutet and Janssen Pharmaceuticals, however, the current project is not related to this collaboration. Hultcrantz has received honoraria from Intellisphere, LLC, not related to this project. The remaining authors declare no conflict of interest.